MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.250
+0.010 (0.81%)
Apr 28, 2026, 4:00 PM EDT - Market closed
MAIA Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 9.72 | 6.95 | 9.07 | 7.24 | 4.29 | |
| Research & Development | 14.55 | 10.01 | 11.11 | 8.93 | 3.5 | |
| Operating Expenses | 24.27 | 16.96 | 20.18 | 16.18 | 7.79 | |
| Operating Income | -24.27 | -16.96 | -20.18 | -16.18 | -7.79 | |
| Interest Expense | - | -0 | -0.01 | -0.01 | -0.83 | |
| Interest & Investment Income | 0.31 | 0.32 | 0.03 | 0 | 0 | |
| Other Non Operating Income (Expenses) | 1.56 | -6.62 | 0.38 | 0.41 | -1.71 | |
| EBT Excluding Unusual Items | -22.4 | -23.25 | -19.77 | -15.77 | -10.32 | |
| Gain (Loss) on Sale of Investments | - | - | - | -0.45 | - | |
| Other Unusual Items | - | - | - | - | -2.26 | |
| Pretax Income | -22.4 | -23.25 | -19.77 | -16.22 | -12.58 | |
| Earnings From Continuing Operations | -22.4 | -23.25 | -19.77 | -16.22 | -12.58 | |
| Minority Interest in Earnings | - | - | - | - | 0.07 | |
| Net Income | -22.4 | -23.25 | -19.77 | -16.22 | -12.5 | |
| Net Income to Common | -22.4 | -23.25 | -19.77 | -16.22 | -12.5 | |
| Shares Outstanding (Basic) | 32 | 22 | 13 | 9 | 5 | |
| Shares Outstanding (Diluted) | 32 | 22 | 13 | 9 | 5 | |
| Shares Change (YoY) | 44.68% | 67.38% | 42.95% | 75.75% | 19.23% | |
| EPS (Basic) | -0.70 | -1.05 | -1.49 | -1.75 | -2.37 | |
| EPS (Diluted) | -0.70 | -1.05 | -1.49 | -1.75 | -2.37 | |
| EBIT | -24.27 | -16.96 | -20.18 | -16.18 | -7.79 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.